1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow XWPharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Valiloxybate (XW10172 MR) Efficacy and Safety Parkinson's Disease Study Valiloxybate, Placebo - Parkinson Disease, Excessive Daytime Somnolence | Phase 2 | Withdrawn | XWPharma | 2021-11-01 | 2025-03-19 |
Disorders of Excessive Somnolence (1) · Parkinson Disease (1)